Geneva, Jan. 12 -- International Clinical Trials Registry received information related to the study (NCT07313124) titled 'Comparative Study Between Antihyperlipidemic Agents in Treatment of Cardiovascular Diseases' on Dec. 17, 2025.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: Beni-Suef University
Condition:
Cardiovascular Diseases (CVD)
Intervention:
Drug: rosuvastatin drug
Recruitment Status: Not recruiting
Phase: Phase 2/Phase 3
Date of First Enrollment: December 15, 2024
Target Sample Size: 66
Countries of Recruitment:
Egypt
To know more, visit https://clinicaltrials.gov/study/NCT07313...